Stock 600998 JOINTOWN PHARMACEUTICAL GROUP CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Jointown Pharmaceutical Group Co., Ltd

Equities

600998

CNE100000W45

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
8.21 CNY +1.61% Intraday chart for Jointown Pharmaceutical Group Co., Ltd -3.41% +17.12%
29/04 Jointown Pharma's Q1 Profit, Revenue Fall 4% MT
29/04 Jointown Pharmaceutical Group's 2023 Profit Jumps 4% MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The company shows low valuation levels, with an enterprise value at 0.24 times its sales.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Analyst opinion has improved significantly over the past four months.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.32B
B+
MCKESSON CORPORATION Stock McKesson Corporation
+14.53% 69.68B
C+
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+7.11% 8.21B
B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.55% 7.96B
B-
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
-4.06% 7.75B
C
H. LUNDBECK A/S Stock H. Lundbeck A/S
+2.32% 4.64B
B-
EBOS GROUP LIMITED Stock EBOS Group Limited
-1.24% 4.09B
B-
GALENICA AG Stock Galenica AG
-3.78% 3.82B
B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+21.42% 3.62B
C+
MEDIPAL HOLDINGS CORPORATION Stock MediPal Holdings Corporation
+8.64% 3.39B
C
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 600998 Stock
  4. Ratings Jointown Pharmaceutical Group Co., Ltd